Domača stranQGEN • NYSE
add
Qiagen NV
Prejšnji trg. dan.
45,02 $
Dnevni razpon
45,50 $ - 46,08 $
Letni razpon
35,81 $ - 47,44 $
Tržna kapitalizacija
10,25 mrd. USD
Povprečni obseg
1,36 mio.
Razm. P/E
143,87
Dividendna donosnost
-
Primarna borza
NYSE
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (USD) | jun. 2024info | Sprememba L/L |
|---|---|---|
Prihodek | 496,35 mio. | 0,30 % |
Stroški poslovanja | 210,33 mio. | −1,80 % |
Čisti dohodek | −183,46 mio. | −327,09 % |
Čista dobičkovnost prihodkov | −36,96 | −326,33 % |
Earnings per share | 0,55 | 4,61 % |
EBITDA | −106,96 mio. | −164,76 % |
Efektivna davčna stopnja | 17,90 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (USD) | jun. 2024info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 890,24 mio. | −33,16 % |
Skupna sredstva | 5,58 mrd. | −12,02 % |
Skupne obveznosti | 2,18 mrd. | −19,98 % |
Celoten lastniški kapital | 3,41 mrd. | — |
Shares outstanding | 222,24 mio. | — |
Razmerje P/B | 2,94 | — |
Donosnost sredstev | −7,04 % | — |
Donosnost kapitala | −8,00 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (USD) | jun. 2024info | Sprememba L/L |
|---|---|---|
Čisti dohodek | −183,46 mio. | −327,09 % |
Denar iz dejavnosti | 166,62 mio. | 49,46 % |
Denar iz naložb | −17,84 mio. | −111,41 % |
Denar iz financiranja | −127,38 mio. | −723,31 % |
Neto sprememba denarnih sredstev | 19,97 mio. | −92,02 % |
Prost denarni tok | 30,94 mio. | −52,45 % |
Vizitka
QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N.V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The Netherlands. The main operative headquarters are located in Hilden, Germany. European, American, Chinese, and Asian-Pacific regional headquarters are located respectively in respectively Hilden, Germany; Germantown, Maryland, United States; Shanghai, China; and Singapore. QIAGEN's shares are listed at the NYSE and at the Frankfurt Stock Exchange in the Prime Standard. Thierry Bernard is the company's Chief Executive Officer. Wikipedia
Generalni direktor
Datum ustanovitve
29. nov. 1984
Sedež organizacije
Spletno mesto
Zaposleni
5.900
